Phase I study of the effects of renal impairment on the pharmacokinetics and safety of satraplatin in patients with refractory solid tumors.
about
A survey of renal impairment pharmacokinetic studies for new oncology drug approvals in the USA from 2010 to early 2015: a focus on development strategies and future directionsPhase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors.An open-label, dose-finding study of the combination of satraplatin and gemcitabine in patients with advanced solid tumors.Behavior of platinum(iv) complexes in models of tumor hypoxia: cytotoxicity, compound distribution and accumulation.
P2860
Phase I study of the effects of renal impairment on the pharmacokinetics and safety of satraplatin in patients with refractory solid tumors.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Phase I study of the effects o ...... with refractory solid tumors.
@ast
Phase I study of the effects o ...... with refractory solid tumors.
@en
type
label
Phase I study of the effects o ...... with refractory solid tumors.
@ast
Phase I study of the effects o ...... with refractory solid tumors.
@en
prefLabel
Phase I study of the effects o ...... with refractory solid tumors.
@ast
Phase I study of the effects o ...... with refractory solid tumors.
@en
P2093
P356
P1433
P1476
Phase I study of the effects o ...... s with refractory solid tumors
@en
P2093
D F Bajorin
D Mulkerin
E G Chiorean
M D Galsky
P304
P356
10.1093/ANNONC/MDR358
P577
2011-08-09T00:00:00Z